Cargando…

A new mouse model of Canavan leukodystrophy displays hearing impairment due to central nervous system dysmyelination

Canavan disease is a leukodystrophy caused by mutations in the ASPA gene. This gene encodes the enzyme that converts N-acetylaspartate into acetate and aspartic acid. In Canavan disease, spongiform encephalopathy of the brain causes progressive mental retardation, motor deficit and death. We have is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carpinelli, Marina R., Voss, Anne K., Manning, Michael G., Perera, Ashwyn A., Cooray, Anne A., Kile, Benjamin T., Burt, Rachel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Limited 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036472/ https://www.ncbi.nlm.nih.gov/pubmed/24682784 http://dx.doi.org/10.1242/dmm.014605

Ejemplares similares

Canavan’s spongiform leukodystrophy (Aspartoacylase deficiency) with emphasis on sonographic features in infancy: description of a case report and review of the literature
por: Rossler, Leon, et al.
Publicado: (2022)

Myelination, Dysmyelination, and Demyelination
por: Jean Harry, G., et al.
Publicado: (1998)

Anti-apoptotic gene Bcl2 is required for stapes development and hearing
por: Carpinelli, M R, et al.
Publicado: (2012)

Congenital hearing impairment associated with peripheral cochlear nerve dysmyelination in glycosylation-deficient muscular dystrophy
por: Morioka, Shigefumi, et al.
Publicado: (2020)

Computational modeling of the effects of auditory nerve dysmyelination
por: Brown, Angus M., et al.
Publicado: (2014)

Loss of Central Auditory Processing in a Mouse Model of Canavan Disease
por: von Jonquieres, Georg, et al.
Publicado: (2014)

A Novel Mutation in Aspartoacylase Gene; Canavan Disease
por: ASHRAFI, Mahmoudreza, et al.
Publicado: (2015)

Strategies to limit dysmyelination during secondary degeneration following neurotrauma
por: Fitzgerald, Melinda
Publicado: (2014)

Megalencephalic leukoencephalopathy with sub cortical cysts: An inherited dysmyelinating disorder
por: Bajaj, Sunil Kumar, et al.
Publicado: (2013)

Assessment of Dysmyelination with RAFFn MRI: Application to Murine MPS I
por: Satzer, David, et al.
Publicado: (2015)

A class-specific effect of dysmyelination on the excitability of hippocampal interneurons
por: Pinatel, Delphine, et al.
Publicado: (2023)

Central and peripheral dysmyelination in a 3‐year‐old girl with ring chromosome 18
por: Lammert, Dawn Brianna, et al.
Publicado: (2019)

Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy
por: von Jonquieres, Georg, et al.
Publicado: (2017)

Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease
por: Arun, Peethambaran, et al.
Publicado: (2010)

Aspartoacylase-LacZ Knockin Mice: An Engineered Model of Canavan Disease
por: Mersmann, Nadine, et al.
Publicado: (2011)

Canavan Disease: Clinical and Laboratory Profile from Southern Part of India
por: Gowda, Vykuntaraju K., et al.
Publicado: (2021)

Canavan Disease as a Model for Gene Therapy-Mediated Myelin Repair
por: Lotun, Anoushka, et al.
Publicado: (2021)

Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease
por: Hertzog, Nadège, et al.
Publicado: (2023)

Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity
por: Mendes, Marisa I, et al.
Publicado: (2017)

Two ENU-Induced Alleles of Atp2b2 Cause Deafness in Mice
por: Carpinelli, Marina R., et al.
Publicado: (2013)

Correction: Two ENU-Induced Alleles of Atp2b2 Cause Deafness in Mice
por: Carpinelli, Marina R., et al.
Publicado: (2013)

The Clinical Features and Diagnosis of Canavan’s Disease: A Case Series of Iranian Patients
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2014)

Preventable infections in children with leukodystrophy
por: Anderson, Holly M, et al.
Publicado: (2014)

Congenital bovine spinal dysmyelination is caused by a missense mutation in the SPAST gene
por: Thomsen, Bo, et al.
Publicado: (2009)

LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?
por: Foale, Simon, et al.
Publicado: (2017)

Dysmyelination by Oligodendrocyte‐Specific Ablation of Ninj2 Contributes to Depressive‐Like Behaviors
por: Sun, Yuxia, et al.
Publicado: (2021)

Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy
por: Reddy, Adarsh S., et al.
Publicado: (2013)

Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV
por: Grishchuk, Yulia, et al.
Publicado: (2014)

Myelopathy in a patient with leukodystrophy due to CSF1R mutation
por: Ho, Victoria M., et al.
Publicado: (2019)

The natural history of Canavan disease: 23 new cases and comparison with patients from literature
por: Bley, Annette, et al.
Publicado: (2021)

Pathological Bergmann glia alterations and disrupted calcium dynamics in ataxic Canavan disease mice
por: Hull, Vanessa L., et al.
Publicado: (2023)

Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs
por: Feng, Lizhao, et al.
Publicado: (2020)

Increasing N-acetylaspartate in the Brain during Postnatal Myelination Does Not Cause the CNS Pathologies of Canavan Disease
por: Appu, Abhilash P., et al.
Publicado: (2017)

CHD7 Deficiency in “Looper”, a New Mouse Model of CHARGE Syndrome, Results in Ossicle Malformation, Otosclerosis and Hearing Impairment
por: Ogier, Jacqueline M., et al.
Publicado: (2014)

Dual-function AAV gene therapy reverses late-stage Canavan disease pathology in mice
por: Fröhlich, Dominik, et al.
Publicado: (2022)

Intermittent lipid nanoparticle mRNA administration prevents cortical dysmyelination associated with arginase deficiency
por: Khoja, Suhail, et al.
Publicado: (2022)

Cytotoxic edema and diffusion restriction as an early pathoradiologic marker in canavan disease: case report and review of the literature
por: Merrill, Steven T., et al.
Publicado: (2016)

Therapeutic development for Canavan disease using patient iPSCs introduced with the wild-type ASPA gene
por: Chao, Jianfei, et al.
Publicado: (2022)

Msh2 deficiency leads to dysmyelination of the corpus callosum, impaired locomotion, and altered sensory function in mice
por: Diouf, Barthelemy, et al.
Publicado: (2016)

Myelin-Independent Therapeutic Potential of Canine Glial-Restricted Progenitors Transplanted in Mouse Model of Dysmyelinating Disease
por: Stanaszek, Luiza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m2aejrhj38ckrektek504tqlna